UCbase & miRfunc: a database of ultraconserved sequences and microRNA function.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMC 2686429)

Published in Nucleic Acids Res on October 22, 2008

Authors

Cristian Taccioli1, Enrica Fabbri, Rosa Visone, Stefano Volinia, George A Calin, Louise Y Fong, Roberto Gambari, Arianna Bottoni, Mario Acunzo, John Hagan, Marilena V Iorio, Claudia Piovan, Giulia Romano, Carlo Maria Croce

Author Affiliations

1: Department of Molecular Virology, Immunology and Medical Genetics, The Ohio State University, Columbus, OH 43210, USA.

Articles citing this

TransmiR: a transcription factor-microRNA regulation database. Nucleic Acids Res (2009) 2.80

Nucleic Acids Research annual Database Issue and the NAR online Molecular Biology Database Collection in 2009. Nucleic Acids Res (2008) 2.25

Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets. PLoS One (2010) 1.59

TAM: a method for enrichment and depletion analysis of a microRNA category in a list of microRNAs. BMC Bioinformatics (2010) 1.49

Transcribed-Ultra Conserved Region expression is associated with outcome in high-risk neuroblastoma. BMC Cancer (2009) 1.29

miRMaid: a unified programming interface for microRNA data resources. BMC Bioinformatics (2010) 1.20

From microRNA functions to microRNA therapeutics: novel targets and novel drugs in breast cancer research and treatment (Review). Int J Oncol (2013) 1.06

Hyper conserved elements in vertebrate mRNA 3'-UTRs reveal a translational network of RNA-binding proteins controlled by HuR. Nucleic Acids Res (2013) 0.86

UCbase 2.0: ultraconserved sequences database (2014 update). Database (Oxford) (2014) 0.85

Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis. Oncotarget (2014) 0.84

Identification of polymorphisms in ultraconserved elements associated with clinical outcomes in locally advanced colorectal adenocarcinoma. Cancer (2012) 0.82

Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review). Int J Oncol (2016) 0.79

The Role of miRNA in Haematological Malignancy. Bone Marrow Res (2013) 0.79

Genetic variants within ultraconserved elements and susceptibility to right- and left-sided colorectal adenocarcinoma. Carcinogenesis (2012) 0.77

Articles cited by this

Basic local alignment search tool. J Mol Biol (1990) 659.07

The human genome browser at UCSC. Genome Res (2002) 168.23

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell (1993) 64.62

A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A (2006) 40.09

Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature (2001) 38.75

NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res (2005) 37.39

The nuclear RNase III Drosha initiates microRNA processing. Nature (2003) 35.49

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2002) 32.26

MicroRNAs modulate hematopoietic lineage differentiation. Science (2003) 30.05

MicroRNA gene expression deregulation in human breast cancer. Cancer Res (2005) 27.56

Database resources of the National Center for Biotechnology Information. Nucleic Acids Res (2007) 22.53

MicroRNA maturation: stepwise processing and subcellular localization. EMBO J (2002) 19.47

NCBI GEO: mining millions of expression profiles--database and tools. Nucleic Acids Res (2005) 17.61

Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet (2002) 17.20

Ultraconserved elements in the human genome. Science (2004) 17.14

The microRNA.org resource: targets and expression. Nucleic Acids Res (2007) 16.26

A pancreatic islet-specific microRNA regulates insulin secretion. Nature (2004) 15.02

TRANSFAC: a database on transcription factors and their DNA binding sites. Nucleic Acids Res (1996) 13.50

Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat (2003) 12.88

Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res (2005) 9.80

MicroRNA signatures in human ovarian cancer. Cancer Res (2007) 9.45

Online Mendelian Inheritance in Man (OMIM). Hum Mutat (2000) 7.54

MicroRNA-cancer connection: the beginning of a new tale. Cancer Res (2006) 7.38

Computational identification of microRNA targets. Dev Biol (2004) 6.84

UNAFold: software for nucleic acid folding and hybridization. Methods Mol Biol (2008) 6.83

Arabidopsis micro-RNA biogenesis through Dicer-like 1 protein functions. Proc Natl Acad Sci U S A (2004) 6.61

miRBase: the microRNA sequence database. Methods Mol Biol (2006) 6.17

A distal enhancer and an ultraconserved exon are derived from a novel retroposon. Nature (2006) 5.98

Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell (2007) 5.40

MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A (2008) 4.33

ArrayExpress service for reviewers/editors of DNA microarray papers. Nat Biotechnol (2006) 3.61

MicroRNAs and the regulation of cell death. Trends Genet (2004) 3.42

The CpG island searcher: a new WWW resource. In Silico Biol (2003) 3.42

Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene (2007) 3.29

General mutation databases: analysis and review. J Med Genet (2007) 3.01

Developmental biology. Encountering microRNAs in cell fate signaling. Science (2005) 2.20

Molecular biology. Glimpses of a tiny RNA world. Science (2001) 2.04

Identifying repeat domains in large genomes. Genome Biol (2006) 1.58

ProMiR II: a web server for the probabilistic prediction of clustered, nonclustered, conserved and nonconserved microRNAs. Nucleic Acids Res (2006) 1.23

Articles by these authors

A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A (2006) 40.09

MicroRNA gene expression deregulation in human breast cancer. Cancer Res (2005) 27.56

A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med (2005) 26.02

miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A (2005) 21.51

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA (2008) 12.26

miRNAs, cancer, and stem cell division. Cell (2005) 12.15

Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A (2006) 10.65

MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA (2007) 9.97

MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A (2007) 9.82

MicroRNA signatures in human ovarian cancer. Cancer Res (2007) 9.45

MicroRNAs in Cancer. Annu Rev Med (2009) 9.37

Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell (2009) 8.62

The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A (2005) 8.60

Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol (2007) 8.05

E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell (2008) 7.56

MicroRNA-cancer connection: the beginning of a new tale. Cancer Res (2006) 7.38

A microRNA signature of hypoxia. Mol Cell Biol (2006) 7.24

A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A (2008) 7.14

Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature (2007) 7.04

MicroRNA expression and function in cancer. Trends Mol Med (2006) 7.02

MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood (2009) 5.87

Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res (2006) 5.72

Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol (2009) 5.56

MicroRNAs--the micro steering wheel of tumour metastases. Nat Rev Cancer (2009) 5.47

MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol (2011) 5.46

Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell (2007) 5.40

MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol (2006) 5.40

Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res (2007) 5.40

MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood (2008) 5.23

Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res (2008) 5.16

Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A (2002) 4.86

Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci U S A (2008) 4.79

miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell (2009) 4.48

Micro-RNA profiling in kidney and bladder cancers. Urol Oncol (2007) 4.35

MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A (2008) 4.33

Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A (2008) 4.26

miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A (2009) 4.15

miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell (2010) 4.07

CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A (2007) 4.06

Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell (2008) 4.01

Retracted A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet (2009) 3.88

MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci U S A (2006) 3.80

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci U S A (2008) 3.77

MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer (2007) 3.53

Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell (2010) 3.52

RNA interference in the clinic: challenges and future directions. Nat Rev Cancer (2010) 3.43

MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov (2013) 3.33

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol (2009) 3.29

A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A (2008) 3.29

MicroRNA 29b functions in acute myeloid leukemia. Blood (2009) 3.19

Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res (2008) 3.16

Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA (2011) 3.16

Regulation of tumor angiogenesis by EZH2. Cancer Cell (2010) 3.10

The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature (2002) 3.02

p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med (2011) 2.93

Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients. J Clin Oncol (2013) 2.86

Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res (2010) 2.82

A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell (2010) 2.78

Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. Blood (2009) 2.68

Reprogramming of miRNA networks in cancer and leukemia. Genome Res (2010) 2.65

Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome (2006) 2.64

Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J (2008) 2.58

CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res (2013) 2.57

microRNA-205 regulates HER3 in human breast cancer. Cancer Res (2009) 2.53

Concern Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci U S A (2003) 2.52

miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res (2012) 2.52

Depletion of TDP-43 affects Drosophila motoneurons terminal synapsis and locomotive behavior. FEBS Lett (2009) 2.48

EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat Med (2011) 2.46

MicroRNA expression profiling using microarrays. Nat Protoc (2008) 2.44

mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer (2007) 2.40

MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res (2008) 2.35

Oncogenic role of miR-483-3p at the IGF2/483 locus. Cancer Res (2010) 2.30

Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology (2009) 2.29

MicroRNAs. Cancer J (2008) 2.28

MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells. Cancer Res (2010) 2.28

microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival. Blood (2010) 2.25